IBRX Stock, ImmunityBio Inc. Information
Stock Information
Get IBRX Alerts
News, Short Squeeze, Breakout and More Instantly...
About ImmunityBio Inc.
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.